Prevalence of high risk human papillomavirus types among Nicaraguan women with histological proved pre-neoplastic and neoplastic lesions of the cervix

Sexually Transmitted Infections

Volumn 82, Issue 4, 2006, Pages 334-336

  Hindryckx, P ^a   Garcia, A ^b   Claeys, Patricia ^c,e   Gonzalez, C ^b   Velasquez, R ^b   Bogers, J ^d   Van Renterghem, L ^c   Cuvelier, C A ^c  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE NICARAGUA   (Nicaragua)

^c GHENT UNIVERSITY   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER SCREENING; CYTOLOGY; DNA HYBRIDIZATION; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; NICARAGUA; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; NICARAGUA; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PREVALENCE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 33747187858     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2006.019745     Document Type: Article

References (11)

1. Ferlay J, Bray F, Pisani P, et al. Globocan 2000: cancer incidence, mortality and prevalence worldwide. IARC Cancerbase, 2001;5. Lyons: IARC Press).
2. Muñoz N, Bosch FX, De Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
3. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
4. Kleter B, van Doorn LJ, ter Schegget J, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998;153:1731-9.
5. Kleter B, Van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridazation line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-17.
6. Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 2003;41:3221-8.
7. Claeys P, Gonzalez C, Gonzalez M, et al. Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women's health clinics in Nicaragua. Sex. Transm Infect 2002;78:204-7.
8. Hopman AH, Smedts F, Dignef W, et al. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV16/18 and numerical chromosome abnormalities. J Pathol 2001;202:23-33.
9. Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesion and cervical cancer: a meta-analysis. Br J Cancer 2003;89:101-5.
10. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
11. Woodman CB, Collins S, Rollason TP, et al. Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia. Lancet 2003;361:40-3.